Drugs / Ex vivo cultured adult allogenic MSCs
Ex vivo cultured adult allogenic MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01091701 | Dec 2011 → May 2013 | ischemic stroke | Stempeutics Research Pvt Ltd | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ex vivo cultured adult allogenic MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01091701 ↗ |
| Modality | Cell therapy | “ex vivo cultured adult allogenic mesenchymal stem cells” NCT01091701 ↗ |
| Route | Intravenous | “Single IV dose of allogenic MSCs” NCT01091701 ↗ |